HLA-G liver expression and HLA-G extended haplotypes are associated with chronic hepatitis C in HIV-negative and HIV-coinfected patients

Copyright © 2020 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 217(2020) vom: 30. Aug., Seite 108482
1. Verfasser: Bertol, Bruna Cristina (VerfasserIn)
Weitere Verfasser: Dias, Fabrício César, Debortoli, Guilherme, Souto, Bruno Mendes, Mendonça, Priscila Baptista, Araújo, Roberta Chaves, Santana, Rodrigo Carvalho, Ramalho, Leandra Náira Zambelli, Castelli, Erick Cruz, Martinelli, Ana de Lourdes Candolo, Mendes-Junior, Celso Teixeira, Carosella, Edgardo Delfino, Donadi, Eduardo Antônio, Moreau, Philippe
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antiviral immunity HCV/HIV-coinfection HLA-G polymorphisms Human leukocyte antigen-G Soluble HLA-G HLA-G Antigens
LEADER 01000naa a22002652 4500
001 NLM310510651
003 DE-627
005 20231225140241.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2020.108482  |2 doi 
028 5 2 |a pubmed24n1035.xml 
035 |a (DE-627)NLM310510651 
035 |a (NLM)32470543 
035 |a (PII)S1521-6616(19)30560-1 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Bertol, Bruna Cristina  |e verfasserin  |4 aut 
245 1 0 |a HLA-G liver expression and HLA-G extended haplotypes are associated with chronic hepatitis C in HIV-negative and HIV-coinfected patients 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 01.02.2021 
500 |a Date Revised 01.02.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2020 Elsevier Inc. All rights reserved. 
520 |a Chronic hepatitis C virus (HCV) infection induces liver damage and the HCV/Human Immunodeficiency Virus (HIV)-coinfection may further contribute to its progression. The HLA-G molecule inhibits innate and adaptive immunity and may be deleterious for chronically virus-infected cells. Thus we studied 204 HCV-mono-infected patients, 142 HCV/HIV-coinfected patients, 104 HIV-mono-infected patients and 163 healthy subjects. HLA-G liver expression was similarly induced in HCV and HCV/HIV specimens, increasing with advanced fibrosis and necroinflammatory activity, and with increased levels of liver function-related enzymes. Plasma soluble HLA-G (sHLA-G) levels were higher in HCV/HIV patients compared to HCV, HIV and to healthy individuals. sHLA-G continued to be higher in coinfected patients even after stratification of samples according to degree of liver fibrosis and necroinflammatory activity when compared to mono-infected patients. Some HLA-G gene haplotypes differentiated patient groups and presented few associations with liver and plasma HLA-G expression. HLA-G thus may help to distinguish patient groups 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Antiviral immunity 
650 4 |a HCV/HIV-coinfection 
650 4 |a HLA-G polymorphisms 
650 4 |a Human leukocyte antigen-G 
650 4 |a Soluble HLA-G 
650 7 |a HLA-G Antigens  |2 NLM 
700 1 |a Dias, Fabrício César  |e verfasserin  |4 aut 
700 1 |a Debortoli, Guilherme  |e verfasserin  |4 aut 
700 1 |a Souto, Bruno Mendes  |e verfasserin  |4 aut 
700 1 |a Mendonça, Priscila Baptista  |e verfasserin  |4 aut 
700 1 |a Araújo, Roberta Chaves  |e verfasserin  |4 aut 
700 1 |a Santana, Rodrigo Carvalho  |e verfasserin  |4 aut 
700 1 |a Ramalho, Leandra Náira Zambelli  |e verfasserin  |4 aut 
700 1 |a Castelli, Erick Cruz  |e verfasserin  |4 aut 
700 1 |a Martinelli, Ana de Lourdes Candolo  |e verfasserin  |4 aut 
700 1 |a Mendes-Junior, Celso Teixeira  |e verfasserin  |4 aut 
700 1 |a Carosella, Edgardo Delfino  |e verfasserin  |4 aut 
700 1 |a Donadi, Eduardo Antônio  |e verfasserin  |4 aut 
700 1 |a Moreau, Philippe  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 217(2020) vom: 30. Aug., Seite 108482  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:217  |g year:2020  |g day:30  |g month:08  |g pages:108482 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2020.108482  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 217  |j 2020  |b 30  |c 08  |h 108482